id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
DEA-2026-0399-0001,DEA,DEA-2026-0399,2026-04969,Notice,,2026-03-13T04:00:00Z,2026,3,2026-03-13T04:00:00Z,2026-05-13T03:59:59Z,2026-03-13T15:08:50Z,2026-04969,1,0,09000064b92124fa
DEA-2026-0397-0001,DEA,DEA-2026-0397,2026-04972,Notice,,2026-03-13T04:00:00Z,2026,3,2026-03-13T04:00:00Z,2026-04-14T03:59:59Z,2026-03-13T14:45:34Z,2026-04972,1,0,09000064b9212c9d
DEA-2026-0401-0001,DEA,DEA-2026-0401,2026-04973,Notice,,2026-03-13T04:00:00Z,2026,3,2026-03-13T04:00:00Z,2026-05-13T03:59:59Z,2026-03-13T15:35:31Z,2026-04973,1,0,09000064b92124fc
DEA-2026-0398-0001,DEA,DEA-2026-0398,2026-04970,Notice,,2026-03-13T04:00:00Z,2026,3,2026-03-13T04:00:00Z,2026-04-14T03:59:59Z,2026-03-13T14:56:07Z,2026-04970,1,0,09000064b92124f9
DEA_FRDOC_0001-0508,DEA,DEA_FRDOC_0001,Designation of Propionyl Chloride as a List I Chemical,Rule,,2026-03-10T04:00:00Z,2026,3,2026-03-10T04:00:00Z,,2026-03-10T16:55:22Z,2026-04657,0,0,09000064b9206be3
DEA-2026-0364-0001,DEA,DEA-2026-0364,2026-04655,Notice,,2026-03-10T04:00:00Z,2026,3,2026-03-10T04:00:00Z,2026-05-12T03:59:59Z,2026-03-10T15:16:01Z,2026-04655,1,0,09000064b9206aa3
DEA-2026-0335-0001,DEA,DEA-2026-0335,2026-04305,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T18:09:28Z,2026-04305,1,0,09000064b91ef642
DEA-2026-0331-0001,DEA,DEA-2026-0331,2026-04289,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T17:25:29Z,2026-04289,1,0,09000064b91edfee
DEA-2026-0336-0001,DEA,DEA-2026-0336,2026-04306,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-05-05T03:59:59Z,2026-03-04T18:21:12Z,2026-04306,1,0,09000064b91ef6b1
DEA-2026-0332-0001,DEA,DEA-2026-0332,2026-04296,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T17:35:12Z,2026-04296,1,0,09000064b91eeb41
DEA-2026-0337-0001,DEA,DEA-2026-0337,2026-04308,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T18:34:04Z,2026-04308,1,0,09000064b91ef6cd
DEA-2026-0334-0001,DEA,DEA-2026-0334,2026-04299,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T17:59:10Z,2026-04299,1,0,09000064b91ef531
DEA-2026-0338-0001,DEA,DEA-2026-0338,2026-04307,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T18:44:47Z,2026-04307,1,0,09000064b91ef6db
DEA-2026-0333-0001,DEA,DEA-2026-0333,2026-04303,Notice,,2026-03-04T05:00:00Z,2026,3,2026-03-04T05:00:00Z,2026-04-04T03:59:59Z,2026-03-04T19:41:44Z,2026-04303,1,0,09000064b91ef744
DEA_FRDOC_0001-0507,DEA,DEA_FRDOC_0001,"Schedules of Controlled Substances: Placement of Clonazolam, Diclazepam, Etizolam, Flualprazolam, and Flubromazolam in Schedule I of the Controlled Substances Act",Rule,,2026-03-02T05:00:00Z,2026,3,2026-03-02T05:00:00Z,,2026-03-02T18:40:50Z,2026-04112,0,0,09000064b91e8fdf
DEA-2026-0298-0001,DEA,DEA-2026-0298,2026-02908,Notice,,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,2026-04-15T03:59:59Z,2026-02-13T16:55:52Z,2026-02908,1,0,09000064b91a975a
DEA-2026-0301-0001,DEA,DEA-2026-0301,2026-02914,Notice,,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,2026-03-17T03:59:59Z,2026-02-13T17:33:21Z,2026-02914,1,0,09000064b91aa585
DEA-2026-0299-0001,DEA,DEA-2026-0299,2026-02909,Notice,,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,2026-04-15T03:59:59Z,2026-02-13T17:08:24Z,2026-02909,1,0,09000064b91a93c0
DEA-2026-0300-0001,DEA,DEA-2026-0300,2026-02911,Notice,,2026-02-13T05:00:00Z,2026,2,2026-02-13T05:00:00Z,2026-04-15T03:59:59Z,2026-02-13T17:22:11Z,2026-02911,1,0,09000064b91aa295
DEA-2026-0265-0001,DEA,DEA-2026-0265,"New Document created by Goodman, Myron Joseph (DEA)",Notice,,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,2026-04-07T03:59:59Z,2026-02-05T17:14:19Z,2026-02232,1,0,09000064b918f95f
DEA_FRDOC_0001-0506,DEA,DEA_FRDOC_0001,Registering Emergency Medical Services Agencies under the Protecting Patient Access to Emergency Medications Act of 2017,Rule,,2026-02-05T05:00:00Z,2026,2,2026-02-05T05:00:00Z,,2026-02-05T17:30:25Z,2026-02288,0,0,09000064b919298b
DEA-2026-0232-0001,DEA,DEA-2026-0232,2026-02230,Notice,,2026-02-04T05:00:00Z,2026,2,2026-02-04T05:00:00Z,2026-04-07T03:59:59Z,2026-02-04T16:51:02Z,2026-02230,1,0,09000064b918f523
DEA-2026-0202-0001,DEA,DEA-2026-0202,2026-01947,Notice,,2026-02-02T05:00:00Z,2026,2,2026-02-02T05:00:00Z,2026-03-05T04:59:59Z,2026-02-02T17:29:25Z,2026-01947,0,0,09000064b9189d44
DEA-2026-0201-0001,DEA,DEA-2026-0201,2026-01946,Notice,,2026-02-02T05:00:00Z,2026,2,2026-02-02T05:00:00Z,,2026-02-02T17:08:20Z,,0,0,09000064b918c18e
DEA-2026-0199-0001,DEA,DEA-2026-0199,2026-01940,Notice,,2026-02-02T05:00:00Z,2026,2,2026-02-02T05:00:00Z,2026-04-04T03:59:59Z,2026-02-02T16:32:26Z,2026-01940,1,0,09000064b918b1d4
DEA-2026-0200-0001,DEA,DEA-2026-0200,2026-01944,Notice,,2026-02-02T05:00:00Z,2026,2,2026-02-02T05:00:00Z,2026-03-05T04:59:59Z,2026-02-02T16:57:28Z,2026-01944,0,0,09000064b918b1d5
DEA-2026-0168-0001,DEA,DEA-2026-0168,2026-01072,Notice,,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,2026-02-21T04:59:59Z,2026-01-31T13:14:08Z,2026-01072,0,0,09000064b917ed7f
DEA-2026-0166-0001,DEA,DEA-2026-0166,2026-01298,Notice,,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,2026-03-25T03:59:59Z,2026-01-26T17:16:39Z,2026-01298,1,0,09000064b9181325
DEA-2026-0167-0001,DEA,DEA-2026-0167,2026-01305,Notice,,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,2026-03-25T03:59:59Z,2026-01-26T17:40:22Z,2026-01305,1,0,09000064b917d077
DEA-2026-0169-0001,DEA,DEA-2026-0169,2026-01194,Notice,,2026-01-26T05:00:00Z,2026,1,2026-01-26T05:00:00Z,2026-02-24T04:59:59Z,2026-01-26T18:09:41Z,2026-01194,0,0,09000064b9181f15
DEA-2023-0057-0003,DEA,DEA-2023-0057,Definition of Cannabimimetic Agents and Assignment of an Administration Controlled Substances Code Number for all Cannabimimetic Agents,Rule,,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T23:44:45Z,2026-00907,0,0,09000064b9161314
DEA-2026-0133-0001,DEA,DEA-2026-0133,Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I,Proposed Rule,,2026-01-20T05:00:00Z,2026,1,2026-01-20T05:00:00Z,,2026-01-20T23:36:31Z,2026-00954,0,0,09000064b916130f
DEA-2026-0133-0004,DEA,DEA-2026-0133,DEA-1442 HHS Letter to DEA 06112025,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:08Z,,0,0,09000064b9162339
DEA-2026-0133-0003,DEA,DEA-2026-0133,DEA-1442 DEA Letter to HHS 11012024,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-02-12T21:01:03Z,,0,1,09000064b9162338
DEA-2026-0133-0002,DEA,DEA-2026-0133,DEA-1442 3-Factor Analysis 2-Fluorodeschloroketamine January 2026,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:02Z,,0,0,09000064b9162337
DEA-2026-0133-0005,DEA,DEA-2026-0133,DEA-1442 HHS Letter to DEA 11082024,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-01-20T23:39:10Z,,0,0,09000064b916233a
DEA-2026-0133-0006,DEA,DEA-2026-0133,DEA-1442 DEA Letter to HHS 05282025,Supporting & Related Material,,2026-01-20T05:00:00Z,2026,1,,,2026-02-12T21:01:51Z,,0,1,09000064b916233b
DEA-2026-0100-0001,DEA,DEA-2026-0100,2026-00833,Notice,,2026-01-16T05:00:00Z,2026,1,2026-01-16T05:00:00Z,2026-03-18T03:59:59Z,2026-01-16T19:59:07Z,2026-00833,1,0,09000064b915c15e
DEA-2025-0075-0014,DEA,DEA-2025-0075,Schedules of Controlled Substances: Placement of 4-Fluoroamphetamine in Schedule I,Rule,,2026-01-15T05:00:00Z,2026,1,2026-01-15T05:00:00Z,,2026-01-16T20:17:00Z,2026-00633,0,0,09000064b9152a07
DEA-2025-0771-0002,DEA,DEA-2025-0771,2025-21720,Notice,,2026-01-12T05:00:00Z,2026,1,2026-01-12T05:00:00Z,2026-01-31T04:59:59Z,2026-01-12T17:18:50Z,2025-21720,0,0,09000064b90a7f7f
DEA-2024-0118-0004,DEA,DEA-2024-0118,Schedules of Controlled Substances: Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I,Rule,,2026-01-12T05:00:00Z,2026,1,2026-01-12T05:00:00Z,,2026-01-13T02:58:59Z,2026-00362,0,0,09000064b913658f
DEA-2025-0951-0002,DEA,DEA-2025-0951,"New Document created by Goodman, Myron Joseph (DEA)",Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,,2026-01-08T17:58:45Z,,0,0,09000064b90f4023
DEA-2026-0068-0001,DEA,DEA-2026-0068,2026-00129,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,2026-02-10T04:59:59Z,2026-01-09T02:07:10Z,2026-00129,0,0,09000064b911c8ca
DEA-2026-0069-0001,DEA,DEA-2026-0069,2026-00128,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,2026-02-10T04:59:59Z,2026-01-09T02:05:38Z,2026-00128,0,0,09000064b911de5c
DEA-2026-0067-0001,DEA,DEA-2026-0067,2026-00130,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,2026-02-10T04:59:59Z,2026-01-17T13:22:53Z,2026-00130,0,0,09000064b911de59
DEA-2026-0070-0001,DEA,DEA-2026-0070,2026-00127,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,2026-02-10T04:59:59Z,2026-01-12T17:08:51Z,2026-00127,0,0,09000064b911de60
DEA-2026-0068-0002,DEA,DEA-2026-0068,2026-00129,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,,2026-01-09T02:11:45Z,2026-00129,0,0,09000064b911fce4
DEA-2026-0071-0001,DEA,DEA-2026-0071,2025-23503,Notice,,2026-01-08T05:00:00Z,2026,1,2026-01-08T05:00:00Z,2026-01-22T04:59:59Z,2026-01-09T02:02:05Z,2025-23503,0,0,09000064b911d8c2
DEA-2026-0035-0001,DEA,DEA-2026-0035,2025-23621,Notice,,2026-01-05T05:00:00Z,2026,1,2026-01-05T05:00:00Z,2026-02-21T04:59:59Z,2026-01-09T02:17:01Z,2025-23621,0,0,09000064b9118449
DEA-2026-0001-0001,DEA,DEA-2026-0001,2025-21177,Notice,,2026-01-05T05:00:00Z,2026,1,2026-01-05T05:00:00Z,2025-12-27T04:59:59Z,2026-01-09T02:21:48Z,2025-21177,0,0,09000064b9118974
DEA-2026-0036-0001,DEA,DEA-2026-0036,2025-23621,Notice,,2026-01-05T05:00:00Z,2026,1,2026-01-05T05:00:00Z,2026-02-21T04:59:59Z,2026-01-09T02:14:31Z,2025-23620,0,0,09000064b911957b
DEA-2026-0002-0001,DEA,DEA-2026-0002,2025-21719,Notice,,2026-01-05T05:00:00Z,2026,1,2026-01-05T05:00:00Z,2026-01-01T04:59:59Z,2026-01-09T02:19:00Z,2025-21719,0,0,09000064b9118a2f
DEA-2026-0034-0001,DEA,DEA-2026-0034,2025-23619,Notice,,2026-01-05T05:00:00Z,2026,1,2026-01-05T05:00:00Z,2026-01-22T04:59:59Z,2026-01-09T01:59:48Z,2025-23619,0,0,09000064b9118427
DEA-2023-0029-41937,DEA,DEA-2023-0029,Fourth Temporary Extension of COVID-19 Telemedicine Flexibilities for Prescription of Controlled Medications,Rule,,2025-12-31T05:00:00Z,2025,12,2025-12-31T05:00:00Z,,2026-01-13T03:01:01Z,2025-24123,0,0,09000064b9113f32
DEA-2023-0147-0004,DEA,DEA-2023-0147,Schedules of Controlled Substances: Placement of N-Desethyl Isotonitazene and N-Piperidinyl Etonitazene in Schedule I,Rule,,2025-12-23T05:00:00Z,2025,12,2025-12-23T05:00:00Z,,2026-01-06T01:10:17Z,2025-23717,0,0,09000064b91067de
DEA-2025-0952-0001,DEA,DEA-2025-0952,2025-23469,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-01-21T04:59:59Z,2025-12-19T19:32:12Z,2025-23469,0,0,09000064b90f4ec6
DEA-2025-0953-0001,DEA,DEA-2025-0953,2025-23467,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-02-18T04:59:59Z,2026-01-09T02:23:39Z,2025-23467,0,0,09000064b90f4eeb
DEA-2025-0951-0001,DEA,DEA-2025-0951,2025-23466,Notice,,2025-12-19T05:00:00Z,2025,12,,,2026-01-09T02:25:15Z,,0,1,09000064b90f4e72
DEA-2025-0954-0001,DEA,DEA-2025-0954,2025-23468,Notice,,2025-12-19T05:00:00Z,2025,12,2025-12-19T05:00:00Z,2026-01-21T04:59:59Z,2025-12-19T19:57:02Z,2025-23468,0,0,09000064b90f4f00
DEA-2025-0918-0003,DEA,DEA-2025-0918,251203 OASH to DEA draft letter 4 synthetic cannabinoids 8FA_signed 12032025,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:36Z,,0,0,09000064b90eed87
DEA-2025-0918-0005,DEA,DEA-2025-0918,4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor Analysis December 2025 DEA,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:42Z,,0,0,09000064b90eed89
DEA-2025-0918-0004,DEA,DEA-2025-0918,4F-MDMB-BUTICA ADB-4en-PINACA 5F-EDMB-PICA MMB-FUBICA 8-Factor December 2025 HHS,Supporting & Related Material,,2025-12-18T05:00:00Z,2025,12,,,2025-12-18T19:22:39Z,,0,0,09000064b90eed88
DEA-2025-0918-0002,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I",Proposed Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,2026-01-16T04:59:59Z,2025-12-23T10:00:13Z,2025-22963,0,0,09000064b90da711
DEA-2025-0918-0001,DEA,DEA-2025-0918,"Schedules of Controlled Substances: Extension of Temporary Placement of 4F-MDMB-BUTICA, ADB-4en-PINACA, 5F-EDMB-PICA, and MMB-FUBICA in Schedule I of the Controlled Substances Act",Rule,,2025-12-16T05:00:00Z,2025,12,2025-12-16T05:00:00Z,,2025-12-16T21:28:16Z,2025-22960,0,0,09000064b90da7df
DEA-2025-0885-0003,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 07102025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:51Z,,0,0,09000064b90d40f8
DEA-2025-0885-0002,DEA,DEA-2025-0885,HHS letter to DEA Bromazolam 06282024,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:46Z,,0,0,09000064b90d40f6
DEA-2025-0885-0001,DEA,DEA-2025-0885,Schedules of Controlled Substances: Temporary Placement of Bromazolam in Schedule I,Proposed Rule,,2025-12-15T05:00:00Z,2025,12,2025-12-15T05:00:00Z,,2025-12-15T20:45:21Z,2025-22763,0,0,09000064b90d3470
DEA-2025-0885-0004,DEA,DEA-2025-0885,DEA 3-Factor Analysis Bromazolam December 2025,Supporting & Related Material,,2025-12-15T05:00:00Z,2025,12,,,2025-12-15T20:47:54Z,,0,0,09000064b90d40f7
DEA-2025-0852-0005,DEA,DEA-2025-0852,HHS Letter to DEA cumyl-PEGACLONE_112024,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:46:04Z,,0,0,09000064b90cb028
DEA-2025-0852-0007,DEA,DEA-2025-0852,HHS Letter to DEA cumyl-PEGACLONE_112024,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:33Z,,0,0,09000064b90cb02a
DEA-2025-0852-0006,DEA,DEA-2025-0852,CUMYL-PEGACLONE HHS 8 Factor Review,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:28Z,,0,0,09000064b90cb029
DEA-2025-0852-0008,DEA,DEA-2025-0852,CUMYL PEGACLONE DEA 8-Factor Analysis_1222025,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:50:36Z,,0,0,09000064b90cb02b
DEA-2025-0852-0004,DEA,DEA-2025-0852,CUMYL-PEGACLONE HHS 8 Factor Review,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:46:02Z,,0,0,09000064b90cb027
DEA-2025-0852-0003,DEA,DEA-2025-0852,CUMYL PEGACLONE DEA 8-Factor Analysis_1222025,Supporting & Related Material,,2025-12-12T05:00:00Z,2025,12,,,2025-12-13T02:45:59Z,,0,0,09000064b90cb026
DEA-2025-0555-0055,DEA,DEA-2025-0555,Schedules of Controlled Substances: Extension of Temporary Placement of MDMB-4en-PINACA in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:41:46Z,2025-22540,0,0,09000064b90c55b5
DEA-2025-0852-0002,DEA,DEA-2025-0852,Schedules of Controlled Substances: Extension of Temporary Placement of CUMYL-PEGACLONE in Schedule I,Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,,2025-12-11T19:46:09Z,2025-22496,0,0,09000064b90c55b7
DEA-2025-0852-0001,DEA,DEA-2025-0852,Schedules of Controlled Substances: Placement of Cumyl-Pegaclone in Schedule I,Proposed Rule,,2025-12-11T05:00:00Z,2025,12,2025-12-11T05:00:00Z,2026-01-13T04:59:59Z,2025-12-24T10:00:21Z,2025-22495,0,0,09000064b90c30e5
DEA-2025-0820-0001,DEA,DEA-2025-0820,2025-21790,Notice,,2025-12-03T05:00:00Z,2025,12,2025-12-03T05:00:00Z,2025-02-04T04:59:59Z,2025-12-03T19:44:43Z,2025-21790,0,0,09000064b90ab305
DEA-2025-0687-0001,DEA,DEA-2025-0687,2025-21192 (1),Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,,2025-12-01T18:33:33Z,,0,0,09000064b90a17a3
DEA-2025-0762-0001,DEA,DEA-2025-0762,2025-21180,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T23:13:28Z,2025-21180,0,0,09000064b90a54c2
DEA-2025-0770-0001,DEA,DEA-2025-0770,2025-21190,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:40:21Z,2025-21190,0,0,09000064b90a7f1d
DEA-2025-0774-0001,DEA,DEA-2025-0774,2025-21724,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T01:23:44Z,2025-21724,0,0,09000064b90a8065
DEA-2025-0772-0001,DEA,DEA-2025-0772,2025-21187,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T01:09:04Z,2025-21187,0,0,09000064b90a7fa4
DEA-2025-0763-0001,DEA,DEA-2025-0763,2025-21181,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-05T10:00:17Z,2025-21181,0,0,09000064b90a54dc
DEA-2025-0757-0001,DEA,DEA-2025-0757,2025-21175,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:24:06Z,2025-21175,0,0,09000064b90a6a09
DEA-2025-0761-0001,DEA,DEA-2025-0761,2025-21179,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T22:02:52Z,2025-21179,0,0,09000064b90a67c5
DEA-2025-0769-0001,DEA,DEA-2025-0769,2025-21189,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-02T00:34:28Z,2025-21189,0,0,09000064b90a7f00
DEA-2025-0768-0001,DEA,DEA-2025-0768,2025-21186,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:15:42Z,2025-21186,0,0,09000064b90a67c7
DEA-2025-0764-0001,DEA,DEA-2025-0764,2025-21182,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T23:36:37Z,2025-21182,0,0,09000064b90a54df
DEA-2025-0773-0001,DEA,DEA-2025-0773,2025-21724,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T01:15:20Z,2025-21724,0,0,09000064b90a7fc6
DEA-2025-0765-0001,DEA,DEA-2025-0765,2025-21183,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T23:43:27Z,2025-21183,0,0,09000064b90a814e
DEA-2025-0753-0001,DEA,DEA-2025-0753,2025-21173,Notice,,2025-12-01T05:00:00Z,2025,12,2025-11-26T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T20:28:41Z,2025-21173,0,0,09000064b90a6905
DEA-2025-0760-0001,DEA,DEA-2025-0760,2025-21178,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:55:42Z,2025-21178,0,0,09000064b90a67c1
DEA-2025-0767-0001,DEA,DEA-2025-0767,2025-21185,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-02T00:03:58Z,2025-21185,0,0,09000064b90a7016
DEA-2025-0759-0001,DEA,DEA-2025-0759,2025-21176,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:42:35Z,2025-21176,0,0,09000064b90a6788
DEA-2025-0720-0001,DEA,DEA-2025-0720,2025-21191,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T20:12:52Z,DEA-2025-0720,0,0,09000064b90a5893
DEA-2025-0756-0001,DEA,DEA-2025-0756,2025-21174,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T21:10:37Z,2025-21174,0,0,09000064b90a69de
DEA-2025-0755-0001,DEA,DEA-2025-0755,2025-21174,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-27T04:59:59Z,2025-12-01T20:45:50Z,2025-21174,0,0,09000064b90a6996
DEA-2025-0758-0001,DEA,DEA-2025-0758,2025-21176,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2025-12-27T04:59:59Z,2025-12-01T21:33:01Z,DEA 2025-21176,0,0,09000064b90a6784
DEA-2025-0771-0001,DEA,DEA-2025-0771,2025-21720,Notice,,2025-12-01T05:00:00Z,2025,12,2025-12-01T05:00:00Z,2026-01-31T04:59:59Z,2025-12-02T00:50:08Z,2025-21720,0,0,09000064b90a7f54